Skip to content
Recall Observatory FDA recall evidence

Drug product

Pramipexole Dihydrochloride Extended Release Tablets, 0.375 mg, Rx Only, 30 count bottles, Manufactured By: Par Pharmaceutical Companies, Inc., Chestnut Ridge, NY 10977, NDC 10370-251-11

D-1038-2016

May 28, 2016

Class III

Product summary

Firm
Par Pharmaceutical
Event
Event 74270
Status
Terminated
Classification
Class III
Quantity
12,535 bottles
Official record key
drug-enforcement:D-1038-2016

Official wording

Reason: Failed Impurities/Degradation Specifications: Par Pharmaceutical is recalling Pramipexole Dihydrochloride Extended Release tablets because it contains a known product impurity above currently approved specification levels.

Code information: Lot #s: 27409201, 27409301, 27409401, Exp. 02/2017; 27662101, Exp. 07/2017

Distribution pattern: Nationwide and Puerto Rico.

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Impurities/Degradation Specifications